Comparison of efficacy of lignocaine, ropivacaine, and bupivacaine in pain control during extraction of mandibular posterior teeth

Nazeer, Jazib; Kumari, Soni; Haidry, Nazia; Kulkarni, P.; Aastha,; Gautam, Ashesh; Gupta, Preeti

doi:10.4103/njms.njms_14_20

Cited by 3 publications

(4 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Mobilization is more difficult if the patient is receiving strong pain medications that impair circulation or cause nausea [ 5 ]. Therefore, to positively influence the postoperative pain situation, intraoperative application of long-lasting local anesthetics is a good way to reduce pain [ 17 , 18 , 19 ]. Usually, these allow early mobilization without the need to give opioids.…”

Section: Discussionmentioning

confidence: 99%

“…Ropivacaine is also infiltrated in the thoracic region (cranial und lateral pectoral muscles, serratus muscle, axilla) and also at the outlet of the drainage, which is almost always required. As a long-acting local anesthetic, ropivacaine has been shown to work better than bupivacaine in some studies, although the latter has become also a valuable component of many ERAS protocols in its liposomal version [ 17 , 20 ].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Enhanced Recovery after Surgery (ERAS) in DIEP-Flap Breast Reconstructions—A Comparison of Two Reconstructive Centers with and without ERAS-Protocol

Linder

Walle

Loucas

et al. 2022

JPM

View full text Add to dashboard Cite

Enhanced recovery after surgery (ERAS) is established for autologous breast reconstruction. ERAS leads to a shortened hospital stay and improved outcome after elective surgery. In this retrospective, two-center case–control study, we compared two different treatment regimens for patients undergoing a DIEP-flap breast reconstruction from two centers, one with an established ERAS protocol and one without. All patients with DIEP breast reconstructions over the period of 12 months were included. The primary outcome measure was the length of hospital stay (LOS) in days. A total of 79 patients with 95 DIEP-flaps were analyzed. In group A (ERAS) 42 patients were operated with DIEP flaps, in group B (non-ERAS) 37 patients. LOS was significantly reduced in the ERAS group (4.51 days) compared to the non-ERAS group (6.32; p < 0.001). Multivariate analysis showed that, in group A, LOS is significantly affected by surgery duration. BMI in the ERAS group had no effect on LOS. In group B a higher BMI resulted in a significantly higher LOS. In multivariate analysis, neither age nor type for surgery (primary/secondary/after neoadjuvant therapy, etc.) affected LOS. In both groups, no systemic or flap-related complications were observed. Comparing two reconstructive centers with and without implemented ERAS, ERAS led to a significantly decreased LOS for all patients. ERAS implementation does not result in an increased complication rate or flap loss. Postoperative pain can be well managed with basic analgesia using NSAID when intraoperative blocks are applied. The reduced use of opioids was well tolerated. With implementation of ERAS the recovery experience can be enhanced making autologous breast reconstructions more available and attractive for various patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Enhanced Recovery after Surgery (ERAS) in DIEP-Flap Breast Reconstructions—A Comparison of Two Reconstructive Centers with and without ERAS-Protocol

Linder

Walle

Loucas

et al. 2022

JPM

View full text Add to dashboard Cite

show abstract

“…The left parotid region was infiltrated with LA consisting of a combination of 10 mL of ropivacaine 1% and 10 mL of mepivacaine 2%, long-acting onset anaesthetics, to reduce the systemic toxicity of mepivacaine[ 5 ] and to ensure adequate pain control. Sensory block was achieved due to the selective block of the smaller pain fibres, leaving the larger motor, touch and proprioception fibres relatively unaffected.…”

Section: Ase R Eportmentioning

confidence: 99%

Partial Parotidectomy under Local Anaesthesia without Regional Block Assisted by Electromyographic Facial Nerve Monitoring - A Case Report

Girotto

Feudis

Balercia

2023

Annals of Maxillofacial Surgery

View full text Add to dashboard Cite

The Rationale: This study describes a partial parotidectomy (PP) under local anaesthesia (LA) without regional block (LAwRB) assisted by electromyographic monitoring of the facial nerve, to consolidate the feasibility, efficacy and safety of these procedures without general anaesthesia (GA). Patient Concerns: An 82-year-old with a lump in the left parotid gland suspected for non-Hodgkin lymphoma (NHL) needed a histological examination to start chemotherapy. Diagnosis and Treatments: Because of multiple comorbidities, the authors performed a PP under LAwRB electromyographically guided by the NIM Vital (Medtronic)™. Outcomes: The procedure was quick and did not require conversion to GA. The histopathological examination confirmed the NHL. No haematoma, sialocoele, earlobe numbness and transient or permanent facial palsy were observed. Take-Away Lessons: The electrophysiologic monitoring of the facial nerve improves the efficacy, safety and feasibility of parotid surgery under LA, avoiding adverse effects of GA, need of regional block and reducing hospital stay.

show abstract

“…Bupivacaine, an amide local anesthetic, is more potent and longer-lasting than other options (12) . Although research in this area is expanding, there is no universally accepted 'gold standard' for post-caesarean pain management.…”

Section: Introductionmentioning

confidence: 99%

Evaluation of Analgesic Effect of Bupivacaine Injection into Both Angles of the Rectus Sheath Incision after an Elective Caesarean Section

Al Gazzar,

Abdelazim,

Soliman

et al. 2023

Benha Medical Journal

View full text Add to dashboard Cite

Background: Pain management after a caesarean section (CS) remains a significant clinical challenge, and alternative strategies for analgesia are continually being explored This study aimed to determine the efficacy of injecting the local anesthetic, Bupivacaine, bilaterally into the rectus sheath incision angles to block the ilioinguinal and ilio-hypogastric nerves, with the aim of reducing postoperative pain in patients undergoing CS under general anesthesia. Methods: A total of 150 female patients scheduled for elective Caesarean section were enrolled in this study. Patients were randomly assigned to one of two groups: Group A received Bupivacaine injections, while Group B received saline injections into the rectus sheath incision angles. Pain assessments, medication usage, and patient satisfaction were evaluated as primary outcome measures. Results: The study revealed that patients in Group A, receiving Bupivacaine injections, experienced significantly lower pain scores at various time intervals, shorter time to the first analgesic request, and a reduced need for meperidine compared to Group B. Additionally, patients in Group A reported higher satisfaction with pain management. Conclusion: Injection of Bupivacaine into both angles of the rectus sheath incision during Caesarean section effectively reduces postoperative pain and improves patient satisfaction.

show abstract

Comparison of efficacy of lignocaine, ropivacaine, and bupivacaine in pain control during extraction of mandibular posterior teeth

Cited by 3 publications

References 17 publications

Enhanced Recovery after Surgery (ERAS) in DIEP-Flap Breast Reconstructions—A Comparison of Two Reconstructive Centers with and without ERAS-Protocol

Enhanced Recovery after Surgery (ERAS) in DIEP-Flap Breast Reconstructions—A Comparison of Two Reconstructive Centers with and without ERAS-Protocol

Partial Parotidectomy under Local Anaesthesia without Regional Block Assisted by Electromyographic Facial Nerve Monitoring - A Case Report

Evaluation of Analgesic Effect of Bupivacaine Injection into Both Angles of the Rectus Sheath Incision after an Elective Caesarean Section

Contact Info

Product

Resources

About